Kysthospitalet in Hagevik, Orthopaedic Department, Haukeland University Hospital, Bergen, Norway.
Division of Orthopaedic Surgery, Oslo University Hospital Ullevål, Oslo, Norway.
BMJ. 2024 Aug 7;386:e079771. doi: 10.1136/bmj-2024-079771.
To assess whether decompression alone is non-inferior to decompression with instrumented fusion five years after primary surgery in patients with degenerative lumbar spondylolisthesis.
Five year follow-up of a randomised, multicentre, non-inferiority trial (Nordsten-DS).
16 public orthopaedic and neurosurgical clinics in Norway.
Patients aged 18-80 years with symptomatic lumbar spinal stenosis and a spondylolisthesis of 3 mm or more at the stenotic level.
Decompression surgery alone and decompression with additional instrumented fusion (1:1).
The primary outcome was a 30% or more reduction in Oswestry disability index from baseline to five year follow-up. The predefined non-inferiority margin was a -15 percentage point difference in the proportion of patients who met the primary outcome. Secondary outcomes included the mean change in Oswestry disability index, Zurich claudication questionnaire, numeric rating scale for leg and back pain, and EuroQol Group 5-Dimension (EQ-5D-3L) questionnaire.
From 12 February 2014 to 18 December 2017, 267 participants were randomly assigned to decompression alone (n=134) and decompression with instrumented fusion (n=133). Of these, 230 (88%) responded to the five year questionnaire: 121 in the decompression group and 109 in the fusion group. Mean age at baseline was 66.2 years (SD 7.6), and 69% were women. In the modified intention-to-treat analysis with multiple imputation of missing data, 84 (63%) of 133 people in the decompression alone group and 81 (63%) of 129 people in the fusion group had a at least a 30% reduction in Oswestry disability index, a difference of 0.4 percentage points. (95% confidence interval (CI) -11.2 to 11.9). The respective results of the per protocol analysis were 65 (65%) of 100 in the decompression alone group and 59 (66%) of 89 in the fusion group, a difference of -1.3 percentage points (95% CI -14.5 to 12.2). Both 95% CIs were higher than the predefined non-inferiority margin of -15%. The mean change in Oswestry disability index from baseline to five years was -17.8 in both groups (mean difference 0.02 (95% CI -3.8 to 3.9)). Results of the other secondary outcomes were in the same direction as the primary outcome. From two to five year follow-up, a new lumbar operation occurred in six (5%) of 123 people in the decompression group and 11 (10%) of 113 people in the fusion group, with a total from baseline to five years of 21 (16%) of 129 people and 23 (18%) of 125, respectively.
In participants with degenerative spondylolisthesis, decompression alone was non-inferior to decompression with instrumented fusion five years after primary surgery. Proportions of subsequent surgeries at the index level or an adjacent lumbar level were no different between the groups.
ClinicalTrials.gov NCT02051374.
评估在退行性腰椎滑脱症患者中,初次手术后 5 年时单纯减压与减压加器械融合的非劣效性。
一项随机、多中心、非劣效性试验(Nordsten-DS)的 5 年随访。
挪威 16 家公立骨科和神经外科诊所。
年龄在 18-80 岁之间,有症状性腰椎管狭窄症和狭窄水平的滑脱 3 毫米或以上的患者。
单纯减压手术和减压加附加器械融合(1:1)。
主要结局是 Oswestry 残疾指数从基线到 5 年随访时下降 30%或更多。预设的非劣效性边界是在符合主要结局的患者比例上相差-15 个百分点。次要结局包括 Oswestry 残疾指数、苏黎世跛行问卷、腿部和背部疼痛数字评分量表以及 EuroQol Group 5-Dimension(EQ-5D-3L)问卷的平均变化。
从 2014 年 2 月 12 日至 2017 年 12 月 18 日,共有 267 名患者被随机分配到单纯减压组(n=134)和减压加器械融合组(n=133)。其中,230 名(88%)对 5 年问卷做出了回应:减压组 121 名,融合组 109 名。基线时的平均年龄为 66.2 岁(SD 7.6),69%为女性。在有缺失数据的多重插补的改良意向治疗分析中,单纯减压组 133 人中 84 人(63%)和融合组 129 人中 81 人(63%)的 Oswestry 残疾指数至少下降了 30%,差异为 0.4 个百分点。(95%置信区间(CI)-11.2 至 11.9)。单纯减压组 100 人中 65 人(65%)和融合组 89 人中 59 人(66%)的方案分析结果分别为-1.3 个百分点(95%CI-14.5 至 12.2)。两个 95%CI 都高于预设的非劣效性边界-15%。从基线到 5 年,两组的 Oswestry 残疾指数平均变化均为-17.8(平均差值 0.02(95%CI-3.8 至 3.9))。其他次要结局的结果与主要结局一致。从 2 年到 5 年的随访中,减压组有 6 人(5%)和融合组有 11 人(10%)在指数水平或相邻腰椎水平进行了新的腰椎手术,从基线到 5 年,减压组有 21 人(16%)和融合组有 23 人(18%)分别进行了手术。
在退行性脊椎滑脱症患者中,初次手术后 5 年时,单纯减压与减压加器械融合的非劣效性。两组在指数水平或相邻腰椎水平的后续手术比例没有差异。
ClinicalTrials.gov NCT02051374。